Autobio Diagnostics Co (SHSE:603658) Cash-to-Debt : 2.10 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Autobio Diagnostics Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 2.10.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Autobio Diagnostics Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Autobio Diagnostics Co's Cash-to-Debt or its related term are showing as below:

SHSE:603658' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.11 Med: 1.91 Max: No Debt
Current: 2.1

During the past 13 years, Autobio Diagnostics Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.11. And the median was 1.91.

SHSE:603658's Cash-to-Debt is ranked better than
51.1% of 863 companies
in the Medical Devices & Instruments industry
Industry Median: 1.91 vs SHSE:603658: 2.10

Autobio Diagnostics Co Cash-to-Debt Historical Data

The historical data trend for Autobio Diagnostics Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Autobio Diagnostics Co Cash-to-Debt Chart

Autobio Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.32

1.82

3.29

8.58

3.02

Autobio Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															1.91	0.82	0.64	3.02	2.10

Competitive Comparison of Autobio Diagnostics Co's Cash-to-Debt

For the Medical Devices subindustry, Autobio Diagnostics Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autobio Diagnostics Co's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's Cash-to-Debt falls into.

Autobio Diagnostics Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Autobio Diagnostics Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2187.06	/	(698.521	+	24.636)
	=	3.02

Autobio Diagnostics Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1582.533	/	(491.335	+	263.667)
	=	2.10

Autobio Diagnostics Co (SHSE:603658) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Autobio Diagnostics Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Autobio Diagnostics Co (SHSE:603658) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016

Website

http://www.autobio.com.cn

Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines